BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17053895)

  • 21. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.
    Price RN; Uhlemann AC; van Vugt M; Brockman A; Hutagalung R; Nair S; Nash D; Singhasivanon P; Anderson TJ; Krishna S; White NJ; Nosten F
    Clin Infect Dis; 2006 Jun; 42(11):1570-7. PubMed ID: 16652314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
    Ashley EA; Stepniewska K; Lindegårdh N; McGready R; Annerberg A; Hutagalung R; Singtoroj T; Hla G; Brockman A; Proux S; Wilahphaingern J; Singhasivanon P; White NJ; Nosten F
    Trop Med Int Health; 2007 Feb; 12(2):201-8. PubMed ID: 17300626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artemether-lumefantrine: an option for malaria.
    Stover KR; King ST; Robinson J
    Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
    Denis MB; Tsuyuoka R; Lim P; Lindegardh N; Yi P; Top SN; Socheat D; Fandeur T; Annerberg A; Christophel EM; Ringwald P
    Trop Med Int Health; 2006 Dec; 11(12):1800-7. PubMed ID: 17176344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study.
    Hatz C; Soto J; Nothdurft HD; Zoller T; Weitzel T; Loutan L; Bricaire F; Gay F; Burchard GD; Andriano K; Lefèvre G; De Palacios PI; Genton B
    Am J Trop Med Hyg; 2008 Feb; 78(2):241-7. PubMed ID: 18256423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania.
    Joseph D; Kabanywanyi AM; Hulser R; Premji Z; Minzi OM; Mugittu K
    Malar J; 2013 Feb; 12():60. PubMed ID: 23399782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy.
    Parikh S; Fehintola F; Huang L; Olson A; Adedeji WA; Darin KM; Morse GD; Murphy RL; Taiwo BO; Akinyinka OO; Adewole IF; Aweeka FT; Scarsi KK
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7852-6. PubMed ID: 26392500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.
    Mutagonda RF; Kamuhabwa AA; Minzi OM; Massawe SN; Maganda BA; Aklillu E
    Malar J; 2016 May; 15(1):278. PubMed ID: 27177586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic efficacy of generic artemether-lumefantrine in the treatment of uncomplicated malaria in Ghana: assessing anti-malarial efficacy amidst pharmacogenetic variations.
    Thomford NE; Kellermann T; Biney RP; Dixon C; Nyarko SB; Ateko RO; Ekor M; Kyei GB
    Malar J; 2024 Apr; 23(1):125. PubMed ID: 38685044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia.
    Jima D; Tesfaye G; Medhin A; Kebede A; Argaw D; Babaniyi O
    East Afr Med J; 2005 Aug; 82(8):387-90. PubMed ID: 16261913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).
    Tiono AB; Tinto H; Alao MJ; Meremikwu M; Tshefu A; Ogutu B; Ouedraogo A; Lingani M; Cousin M; Lefèvre G; Jain JP; Duparc S; Hamed K
    Malar J; 2015 Apr; 14():157. PubMed ID: 25886021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.
    Ezzet F; Mull R; Karbwang J
    Br J Clin Pharmacol; 1998 Dec; 46(6):553-61. PubMed ID: 9862244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
    van Vugt M; Looareesuwan S; Wilairatana P; McGready R; Villegas L; Gathmann I; Mull R; Brockman A; White NJ; Nosten F
    Trans R Soc Trop Med Hyg; 2000; 94(5):545-8. PubMed ID: 11132386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial.
    Rahman MM; Dondorp AM; Day NP; Lindegardh N; Imwong M; Faiz MA; Bangali AM; Kamal AT; Karim J; Kaewkungwal J; Singhasivanon P
    Trans R Soc Trop Med Hyg; 2008 Sep; 102(9):861-7. PubMed ID: 18606428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malaria.
    van Agtmael MA; Cheng-Qi S; Qing JX; Mull R; van Boxtel CJ
    Int J Antimicrob Agents; 1999 Jul; 12(2):151-8. PubMed ID: 10418761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy.
    Ukah M; Badejoko O; Ogunniyi S; Loto O; Aboderin O; Fatusi A
    Int J Gynaecol Obstet; 2015 Oct; 131(1):41-4. PubMed ID: 26169336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT study.
    Denoeud-Ndam L; Dicko A; Baudin E; Guindo O; Grandesso F; Sagara I; Lasry E; Palma PP; Parra AM; Stepniewska K; Djimde AA; Barnes KI; Doumbo OK; Etard JF
    BMC Infect Dis; 2015 Jun; 15():228. PubMed ID: 26068100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
    ; Pekyi D; Ampromfi AA; Tinto H; Traoré-Coulibaly M; Tahita MC; Valéa I; Mwapasa V; Kalilani-Phiri L; Kalanda G; Madanitsa M; Ravinetto R; Mutabingwa T; Gbekor P; Tagbor H; Antwi G; Menten J; De Crop M; Claeys Y; Schurmans C; Van Overmeir C; Thriemer K; Van Geertruyden JP; D'Alessandro U; Nambozi M; Mulenga M; Hachizovu S; Kabuya JB; Mulenga J
    N Engl J Med; 2016 Mar; 374(10):913-27. PubMed ID: 26962727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem) for bioequivalence in a randomized, open-label, two-period study.
    Lefèvre G; Bhad P; Jain JP; Kalluri S; Cheng Y; Dave H; Stein DS
    Malar J; 2013 Sep; 12():312. PubMed ID: 24010572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.